Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Goodwill (2023 - 2024)

Perspective Therapeutics (CATX) has disclosed Goodwill for 2 consecutive years, with $24.1 million as the latest value for Q3 2024.

  • Quarterly Goodwill fell 11.78% to $24.1 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $24.1 million through Sep 2024, down 11.78% year-over-year, with the annual reading at $24.1 million for FY2023, N/A changed from the prior year.
  • Goodwill hit $24.1 million in Q3 2024 for Perspective Therapeutics, roughly flat from $24.1 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $27.3 million in Q1 2023 to a low of $24.1 million in Q4 2023.